Literature DB >> 5096533

Genetic control of nortriptyline kinetics in man: a study of relatives of propositi with high plasma concentrations.

M Asberg, D A Evans, F Sjöqvist.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5096533      PMCID： PMC1468995          DOI： 10.1136/jmg.8.2.129

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  6 in total

1.  Application of isotope derivative technique to assay of secondary amines: estimation of desipramine by acetylation with H3-acetic anhydride.

Authors:  W M Hammer; B B Brodiet
Journal:  J Pharmacol Exp Ther       Date:  1967-09       Impact factor: 4.030

2.  Plasma protein binding of tricyclic anti-depressants in man.

Authors:  O Borgå; D L Azarnoff; G P Forshell; F Sjöqvist
Journal:  Biochem Pharmacol       Date:  1969-09       Impact factor: 5.858

3.  Plasma levels of monomethylated tricyclic antidepressants during treatment with imipramine-like compounds.

Authors:  W Hammer; F Sjöqvist
Journal:  Life Sci       Date:  1967-09-01       Impact factor: 5.037

4.  Correlation of subjective side effects with plasma concentrations of nortriptyline.

Authors:  M Asberg; B Cronholm; F Sjöqvist; D Tuck
Journal:  Br Med J       Date:  1970-10-03

5.  Predisposing factors in adverse reactions to drugs.

Authors:  N Hurwitz
Journal:  Br Med J       Date:  1969-03-01

6.  Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy.

Authors:  B Alexanderson; D A Evans; F Sjöqvist
Journal:  Br Med J       Date:  1969-12-27
  6 in total
  12 in total

1.  Prediction of steady-state plasma levels of nortriptyline from single oral dose kinetics: a study in twins.

Authors:  B Alexanderson
Journal:  Eur J Clin Pharmacol       Date:  1973-06       Impact factor: 2.953

2.  Pharmacokinetics of nortriptyline in man after single and multiple oral doses: the predictability of steady-state plasma concentrations from single-dose plasma-level data.

Authors:  B Alexanderson
Journal:  Eur J Clin Pharmacol       Date:  1972-03       Impact factor: 2.953

3.  Antidepressants and barbiturates.

Authors:  G D Burrows; B Davies
Journal:  Br Med J       Date:  1971-10-09

4.  The role of drug interactions in interindividual variability of drug metabolism in man.

Authors:  F Sjöqvist
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977       Impact factor: 3.000

Review 5.  Assessment of methods to identify sources of interindividual pharmacokinetic variations.

Authors:  E S Vesell; M B Penno
Journal:  Clin Pharmacokinet       Date:  1983 Sep-Oct       Impact factor: 6.447

Review 6.  Defective oxidation of drugs: pharmacokinetic and therapeutic implications.

Authors:  M Eichelbaum
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

7.  Quantitative pharmacogenetics of nortriptyline: a novel approach.

Authors:  E E Kvist; A Al-Shurbaji; M L Dahl; C Nordin; G Alván; L Ståhle
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

8.  Steady-state plasma levels of nortriptyline and its 10-hydroxy metabolite: relationship to the CYP2D6 genotype.

Authors:  M L Dahl; L Bertilsson; C Nordin
Journal:  Psychopharmacology (Berl)       Date:  1996-02       Impact factor: 4.530

9.  Desipramine pharmacokinetics in Chinese and Caucasian volunteers.

Authors:  M V Rudorfer; E A Lane; W H Chang; M D Zhang; W Z Potter
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

Review 10.  Recent advances in antidepressant drug treatment.

Authors:  S E Ericksen
Journal:  West J Med       Date:  1979-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.